Watchlist Price Alert

Theseus Pharmaceuticals I... (THRX)

NASDAQ: THRX · Real-Time Price · USD

4.07

0.01 (0.25%)

At close: Feb 13, 2024, 8:59 PM

Theseus Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-50.61M	-27.31M	-12M	-7.18M
Depreciation & Amortization	50K	2K	2K	2K
Stock-Based Compensation	11.41M	4.36M	1.05M	317K
Other Working Capital	2.58M	-4.1M	84K	-372K
Other Non-Cash Items	-350K	4.36M	5.16M	2.24M
Deferred Income Tax	n/a	-4.36M	n/a	n/a
Change in Working Capital	6.55M	-4.25M	933K	-179K
Operating Cash Flow	-32.95M	-27.19M	-4.85M	-4.81M
Capital Expenditures	-455K	12K	n/a	n/a
Cash Acquisitions	116.84K	n/a	n/a	n/a
Purchase of Investments	-191.44M	n/a	n/a	n/a
Sales Maturities Of Investments	74.6M	n/a	n/a	n/a
Other Investing Acitivies	-116.84K	n/a	n/a	n/a
Investing Cash Flow	-117.29M	12K	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	182K	263.78M	11.99M	2.99M
Financial Cash Flow	182.00	263.78M	11.99M	2.99M
Net Cash Flow	-150.06M	236.58M	7.14M	-1.81M
Free Cash Flow	-33.4M	-27.18M	-4.85M	-4.81M